14
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Unmet needs in Cushing’s syndrome: the patients’ perspective

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Cushing’s syndrome (CS) is a rare condition of chronically elevated cortisol levels resulting in diverse comorbidities, many of which endure beyond successful treatment affecting the quality of life. Few data are available concerning patients’ experiences of diagnosis, care and persistent comorbidities.

          Objective

          To assess CS patients’ perspectives on the diagnostic and care journey to identify unmet therapeutic needs.

          Methods

          A 12-item questionnaire was circulated in 2019 by the World Association for Pituitary Organisations. A parallel, 13-item questionnaire assessing physician perceptions on CS patient experiences was performed.

          Results

          Three hundred twenty CS patients from 30 countries completed the questionnaire; 54% were aged 35–54 and 88% were female; 41% were in disease remission. The most burdensome symptom was obesity/weight gain (75%). For 49% of patients, time to diagnosis was over 2 years. Following treatment, 88.4% of patients reported ongoing symptoms including, fatigue (66.3%), muscle weakness (48.8%) and obesity/weight gain (41.9%). Comparisons with delay in diagnosis were significant for weight gain ( P = 0.008) and decreased libido ( P = 0.03). Forty physicians completed the parallel questionnaire which showed that generally, physicians poorly estimated the prevalence of comorbidities, particularly initial and persistent cognitive impairment. Only a minority of persistent comorbidities (occurrence in 1.3–66.3%; specialist treatment in 1.3–29.4%) were managed by specialists other than endocrinologists. 63% of patients were satisfied with treatment.

          Conclusion

          This study confirms the delay in diagnosing CS. The high prevalence of persistent comorbidities following remission and differences in perceptions of health between patients and physicians highlight a probable deficiency in effective multidisciplinary management for CS comorbidities.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

          The objective is to formulate clinical practice guidelines for treating Cushing's syndrome.
            • Record: found
            • Abstract: found
            • Article: not found

            Cushing's syndrome.

            Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's syndrome, including debilitating morbidities and increased mortality. Genetic and molecular mechanisms responsible for excess cortisol secretion by primary adrenal lesions and adrenocorticotropic hormone (ACTH) secretion from corticotroph or ectopic tumours have been identified. New biochemical and imaging diagnostic approaches and progress in surgical and radiotherapy techniques have improved the management of patients. The therapeutic goal is to normalise tissue exposure to cortisol to reverse increased morbidity and mortality. Optimum treatment consisting of selective and complete resection of the causative tumour is necessay to allow eventual normalisation of the hypothalamic-pituitary-adrenal axis, maintenance of pituitary function, and avoidance of tumour recurrence. The development of new drugs offers clinicians several choices to treat patients with residual cortisol excess. However, for patients affected by this challenging syndrome, the long-term effects and comorbidities associated with hypercortisolism need ongoing care.
              • Record: found
              • Abstract: found
              • Article: not found

              The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.

              The European Registry on Cushing's syndrome (ERCUSYN) is designed to collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Baseline data on 481 CS patients (390 females, 91 males; mean age (±s.d.): 44±14 years) collected from 36 centres in 23 countries, including new patients from 2008 and retrospective cases since 2000. Patients were divided into four major aetiologic groups: pituitary-dependent CS (PIT-CS) (66%), adrenal-dependent CS (ADR-CS) (27%), CS from an ectopic source (ECT-CS) (5%) and CS from other aetiologies (2%). Proportion of men in the ECT-CS group was higher than in the other groups (P<0.05). The ADR-CS group was older than the PIT-CS (P<0.05). Prevalence of hirsutism (92%) and diabetes (74%) in ECT-CS was higher than in the other groups (P<0.05 and P<0.01 respectively). PIT-CS had more skin alterations, menstrual irregularities and hirsutism than ADR-CS (P<0.01). Reduced libido was more prevalent in men than women (P<0.01). Prevalence of spine osteoporosis was higher in men than women (P<0.05), and males had more vertebral and rib fractures than females (52 vs 18% for vertebrae; P<0.001 and 34 vs 23% for ribs; P<0.05). ECT-CS consulted a diabetologist more frequently than ADR-CS (P<0.05), while a gynaecologist was consulted more often by women with PIT-CS or ADR-CS than with ECT-CS (P<0.05). Overall, weight gain was more common in women than men (P<0.01). CushingQoL and EuroQoL visual analogue scale scores did not differ between the groups. The ERCUSYN project demonstrates a heterogeneous clinical presentation of CS at a European level, depending on gender and aetiology.

                Author and article information

                Journal
                Endocr Connect
                Endocr Connect
                EC
                Endocrine Connections
                Bioscientifica Ltd (Bristol )
                2049-3614
                27 May 2022
                01 July 2022
                : 11
                : 7
                : e220027
                Affiliations
                [1 ]Endocrinology Department , Germans Trias i Pujol Hospital and Research Institute, Badalona, Barcelona, Spain
                [2 ]Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) , Madrid, Spain
                [3 ]Universitat Internacional de Catalunya (UIC) , Barcelona, Spain
                [4 ]IRCCS , Istituto Auxologico Italiano, Milan, Italy
                [5 ]Department of Medical Biotechnology and Translational Medicine , University of Milan, Milan, Italy
                [6 ]Division of Endocrinology , Erasmus Medical Centre, Rotterdam, Netherlands
                [7 ]Division of Endocrinology and Centre for Endocrine Tumours , Leiden University Medical Centre, Leiden, Netherlands
                [8 ]HRA Pharma Rare Diseases , Châtillon, France
                [9 ]Department of Endocrinology and INSERM U862 University and CHU of Bordeaux , Pessac, France
                Author notes
                Correspondence should be addressed to E Valassi: evalassi.germanstrias@ 123456gencat.cat
                Author information
                http://orcid.org/0000-0002-3864-0105
                Article
                EC-22-0027
                10.1530/EC-22-0027
                9254293
                35904235
                d15be3d8-5bbc-4a20-b691-8aaf623f5ed9
                © The authors

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 01 May 2022
                : 27 May 2022
                Categories
                Research

                cushing’s syndrome,management,patient experience,patient survey,quality of life

                Comments

                Comment on this article

                Related Documents Log